In particular, analysis of aqueous and vitreous humors as well as tears, in connection with direct imaging of the retina, could be a promising, non-invasive or minimally invasive approach to initiate the use of Reelin as an early biomarker for AMD or AD [40,65]. This evidence concerns the gene RELN and Alzheimer disease.